Departamento de Genética, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Pacheco de Melo 3081, Ciudad de Buenos Aires (CP 1425), Argentina; E-Mails:
Int J Mol Sci. 2011;12(10):7271-85. doi: 10.3390/ijms12107271. Epub 2011 Oct 24.
The factor VIII gene (F8) intron 22 inversion (Inv22) is a paradigmatic duplicon-mediated rearrangement, found in about one half of patients with severe hemophilia A worldwide. The identification of this prevalent cause of hemophilia was delayed for nine years after the F8 characterization in 1984. The aim of this review is to present the wide diversity of practical approaches that have been developed for genotyping the Inv22 (and related int22h rearrangements) since discovery in 1993. The sequence- Southern blot, long distance-PCR and inverse shifting-PCR-for Inv22 genotyping is an interesting example of scientific ingenuity and evolution in order to resolve challenging molecular diagnostic problems.
凝血因子 VIII 基因(F8)内含子 22 倒位(Inv22)是一个典型的重复序列介导的重排,在全世界约一半的严重血友病 A 患者中发现。这种常见的血友病致病原因在 1984 年 F8 特征描述后 9 年才被确定。本综述的目的是展示自 1993 年发现以来,为 Inv22(和相关的 int22h 重排)基因分型而开发的广泛的实用方法的多样性。用于 Inv22 基因分型的序列- Southern 印迹、长距离-PCR 和反向移位-PCR 是为了解决具有挑战性的分子诊断问题而展现出的科学创造力和演变的有趣例子。